导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.12% | 768/1050 |
| 近一周 | -2.23% | 503/1104 |
| 近一月 | -2.63% | 295/1102 |
| 近一季 | 0.40% | 227/1092 |
| 近半年 | -4.58% | 587/1070 |
| 近一年 | -9.37% | 737/1018 |
| 近两年 | 12.48% | 830/926 |
| 近三年 | -3.40% | 704/834 |
| 成立以来 | 14.75% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.69% 938/1070 |
-4.89% 789/1101 |
- - |
- - |
| 2025 | 5.48% 881/1065 |
1.47% 685/1014 |
-3.01% 895/1038 |
9.38% 862/1050 |
-2.02% 555/1065 |
| 2024 | 4.49% 444/1011 |
3.46% 148/960 |
-2.75% 487/983 |
12.06% 452/991 |
-7.33% 792/1011 |
| 2023 | -7.24% 261/952 |
5.28% 306/880 |
-5.32% 547/895 |
-2.58% 187/915 |
-4.48% 451/952 |
| 2022 | -8.16% 62/867 |
-16.43% 324/773 |
10.07% 264/806 |
-4.88% 64/845 |
4.96% 208/867 |
| 2021 | -8.21% 464/740 |
7.74% 22/580 |
-9.15% 575/659 |
-15.50% 619/704 |
10.99% 55/740 |
| 2020 | 28.74% 355/554 |
-10.03% 381/419 |
15.62% 339/466 |
10.56% 239/517 |
11.95% 295/554 |
| 2019 | - - |
- - |
- - |
- - |
6.35% 300/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 合煦智远消费主题股票发起式A VS. 东吴新产业精选股票A(580008) |